Answer
The terminal elimination half-lives of Juluca’s active components are approximately 14 hours for dolutegravir and 45 hours for rilpivirine.
Sources for this answer
- Juluca 50 mg/25 mg film-coated tabletsViiV Healthcare UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 19Document updated
Sources checked